Antibody Targeting of the CC Chemokine Ligand 5 Results in Diminished Leukocyte Infiltration into the Central Nervous System and Reduced Neurologic Disease in a Viral Model of Multiple Sclerosis1
暂无分享,去创建一个
[1] P. Masters,et al. CXC Chemokine Ligand 10 Controls Viral Infection in the Central Nervous System: Evidence for a Role in Innate Immune Response through Recruitment and Activation of Natural Killer Cells , 2004, Journal of Virology.
[2] W. Glass,et al. Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system , 2003, Virology.
[3] T. Owens. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. , 2003, Current opinion in neurology.
[4] W. Kuziel,et al. CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection , 2003, Journal of Virology.
[5] S. Perlman,et al. Bystander CD4 T cells do not mediate demyelination in mice infected with a neurotropic coronavirus , 2003, Journal of Neuroimmunology.
[6] W. Glass,et al. Functional Expression of Chemokine Receptor CCR5 on CD4+ T Cells during Virus-Induced Central Nervous System Disease , 2003, Journal of Virology.
[7] T. Owens,et al. Chemokines in experimental autoimmune encephalomyelitis and multiple sclerosis. , 2003, Advances in experimental medicine and biology.
[8] J. Van Damme,et al. Macrophage inflammatory protein-1. , 2002, Cytokine & growth factor reviews.
[9] R. Ransohoff. The chemokine system in neuroinflammation: an update. , 2002, The Journal of infectious diseases.
[10] S. Perlman,et al. Bystander CD8 T Cell-Mediated Demyelination After Viral Infection of the Central Nervous System1 , 2002, The Journal of Immunology.
[11] S. Perlman,et al. CD4 T-Cell-Mediated Demyelination Is Increased in the Absence of Gamma Interferon in Mice Infected with Mouse Hepatitis Virus , 2002, Journal of Virology.
[12] M. Perretti,et al. Chemokines as novel therapeutic targets in inflammatory diseases. , 2002, Biochemical pharmacology.
[13] Roland Martin,et al. The immunopathogenesis of multiple sclerosis. , 2002, Journal of rehabilitation research and development.
[14] S. Perlman,et al. Cutting Edge: CD8 T Cell-Mediated Demyelination Is IFN-γ Dependent in Mice Infected with a Neurotropic Coronavirus1 , 2002, The Journal of Immunology.
[15] M. Parmentier,et al. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. , 2001, Blood.
[16] P. Kivisäkk,et al. Chemokine-based therapies for MS: how do we get there from here? , 2001, Trends in immunology.
[17] W. Kuziel,et al. Lack of CCR2 Results in Increased Mortality and Impaired Leukocyte Activation and Trafficking Following Infection of the Central Nervous System with a Neurotropic Coronavirus1 , 2001, The Journal of Immunology.
[18] H. Keirstead,et al. Neutralization of the Chemokine CXCL10 Reduces Inflammatory Cell Invasion and Demyelination and Improves Neurological Function in a Viral Model of Multiple Sclerosis1 , 2001, The Journal of Immunology.
[19] W. Kuziel,et al. Reduced Macrophage Infiltration and Demyelination in Mice Lacking the Chemokine Receptor CCR5 Following Infection with a Neurotropic Coronavirus , 2001, Virology.
[20] S. Perlman,et al. High-Magnitude, Virus-Specific CD4 T-Cell Response in the Central Nervous System of Coronavirus-Infected Mice , 2001, Journal of Virology.
[21] T. Hamilton,et al. Expression of Mig (Monokine Induced by Interferon-γ) Is Important in T Lymphocyte Recruitment and Host Defense Following Viral Infection of the Central Nervous System1 , 2001, Journal of Immunology.
[22] V. Rivera,et al. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1α by interferon-β , 2001, Journal of Neuroimmunology.
[23] C. D. DE GROOT,et al. Macrophage inflammatory protein‐1α (MIP‐1α), MIP‐1β, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions , 2000 .
[24] V. Rivera,et al. Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. , 2000, Brain : a journal of neurology.
[25] M. Buchmeier,et al. Cutting Edge: The T Cell Chemoattractant IFN-Inducible Protein 10 Is Essential in Host Defense Against Viral-Induced Neurologic Disease1 , 2000, The Journal of Immunology.
[26] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[27] D. Hinton,et al. Contributions of Fas-Fas Ligand Interactions to the Pathogenesis of Mouse Hepatitis Virus in the Central Nervous System , 2000, Journal of Virology.
[28] M. Buchmeier,et al. A Central Role for CD4+ T Cells and RANTES in Virus-Induced Central Nervous System Inflammation and Demyelination , 2000, Journal of Virology.
[29] Gregory F. Wu,et al. CD4 and CD8 T Cells Have Redundant But Not Identical Roles in Virus-Induced Demyelination , 2000 .
[30] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[31] C. Mackay,et al. The role of chemokine receptors in primary, effector, and memory immune responses. , 2000, Annual review of immunology.
[32] Gregory F. Wu,et al. Macrophage Infiltration, but Not Apoptosis, Is Correlated with Immune-Mediated Demyelination following Murine Infection with a Neurotropic Coronavirus , 1999, Journal of Virology.
[33] H. Weiner,et al. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] Jakob S. Jensen,et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.
[35] R. Strieter,et al. Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1 , 1998, Journal of Neuroimmunology.
[36] D. Hinton,et al. CTL effector function within the central nervous system requires CD4+ T cells. , 1998, Journal of immunology.
[37] M. Buchmeier,et al. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. , 1998, Journal of immunology.
[38] S. Perlman,et al. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus. , 1997, Virology.
[39] R. Ménard,et al. Gene targeting in malaria parasites. , 1997, Methods.
[40] M. Buchmeier,et al. Murine coronavirus infection: a paradigm for virus-induced demyelinating disease , 1997, Trends in Microbiology.
[41] D. Hinton,et al. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis , 1997, Journal of virology.
[42] A. Krensky,et al. Gene expression of RANTES. , 1997, Methods in enzymology.
[43] Q. Yao,et al. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response. , 1996, The Journal of general virology.
[44] F. Homberger. [Mouse hepatitis virus]. , 1996, Schweizer Archiv fur Tierheilkunde.
[45] S. Perlman,et al. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity , 1995, Journal of virology.
[46] S. Perlman,et al. Identification of a CD4+ T Cell Epitope within the M Protein of a Neurotropic Coronavirus , 1995, Virology.
[47] M. Buchmeier,et al. Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo , 1994, Journal of virology.
[48] M. Burdick,et al. Specific ELISAs for the detection of human macrophage inflammatory protein-1 alpha and beta. , 1993, Immunological investigations.
[49] S. Perlman,et al. Immune response to a murine coronavirus: Identification of a homing receptor-negative CD4+ T cell subset that responds to viral glycoproteins , 1992, Virology.
[50] J. Fleming,et al. Sequence analysis of the spike protein gene of murine coronavirus variants: Study of genetic sites affecting neuropathogenicity , 1992, Virology.
[51] J. Fleming,et al. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated , 1990, Journal of Neuroimmunology.
[52] C. Milstein,et al. Antibodies to major histocompatibility antigens produced by hybrid cell lines , 1977, Nature.
[53] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.